Communiqués Medistim ASA

Actions

MEDI

NO0010159684

Equipement et technologie médicale avancés

Marché Fermé - Oslo Bors Autres places de cotation 16:45:00 21/07/2026			Varia. 5j.	Varia. 1 janv.
223,00 ^NOK	-1,33%		-1,76%	-13,90%

10/06	Odin Small Cap progresse de 4,90 % en mai - légère réduction de la ligne Mycronic	FW
12/05	Danske Bank relève son objectif de cours sur Medistim à 320 NOK (310), maintient son conseil à l'achat - BN	FW

Communiqués

12/05	Medistim : Major shareholder disclosure in Medistim ASA	PU
07/05	Medistim : 2026 the presentation	PU
07/05	Ex dividend NOK 8.00 today	AQ
07/05	First quarter financial results 2026 for Medistim ASA	AQ
06/05	Protocol from the General Meeting in Medistim ASA where a dividend of NOK 8.00 per share was decided	AQ
30/04	Dividend proposal for 2025 Medistim ASA - Key information - correction	AQ
28/04	First quarter results and financials for 2026 for Medistim ASA	AQ
28/04	Dividend proposal for 2025 Medistim ASA - Key information	AQ
17/04	CEO share program- Correction	AQ
17/04	Medistim : CEO share program	PU
14/04	Notice of Annual General Meeting in Medistim ASA	AQ
14/04	Board approval of the 2025 Financial statements for Medistim ASA	AQ
31/03	Financial calendar	AQ
18/03	Medistim : Intertrade Shipping AS purchases Medistim shares	PU
13/03	Intertrade Shipping AS purchases Medistim shares	AQ
27/02	Fourth quarter results and preliminary financials for 2025 for Medistim ASA	AQ
24/02	Medistim sponsors RCT trial comparing the use of TTFM with non-use in CABG	AQ
20/02	Fourth quarter results and preliminary financials for 2025 for Medistim ASA	AQ
03/02	Medistim is opening a direct sales office in Japan	AQ
12/11	Management in Medistim ASA purchases shares	AQ
10/11	Medistim : Management in Medistim ASA purchases shares	PU
24/10/25	Medistim : 2025 Q3 Results Result	PU
24/10/25	Financial results for the third quarter and YTD September 2025 for Medistim ASA	AQ
17/10/25	Third quarter and year-to-date September results and financials for 2025 for Medistim ASA	AQ
12/09/25	Major shareholder disclosure	AQ